# US 2013/0296553 A1 · Vinyl quinuclidine useful as a synthesis intermediate in the preparation of (r)-mequitazine

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0296553 A1
- Document ID: US20130296553A1
- Status: Published application
- Kind: A1
- Application number: 13/822,649
- Filed: 2012-01-10
- Published: 2013-11-07
- Earliest claimed: 2011-01-10
- Assignees: Commissariat A L'energie Atomique Et Aux Energies Alternatives; Pierre Fabre Medicament
- Inventors: Marc Nicolas; Laurent Larquetoux; Sébastien Leroux; Eric Doris
- Web page: https://patentgrep.com/patent/US20130296553A1

## CPC

- C07D 453/02: containing not further condensed quinuclidine ring systems
- A61P 11/02: Nasal agents, e.g. decongestants
- A61P 17/00: Drugs for dermatological disorders
- A61P 37/08: Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14)
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to the use of the vinyl quinuclidine enantiomer (R) of the following formula 2 as a synthesis intermediate in the preparation of (R)-mequitazine.

## Claims

### Claim 1

(canceled)

### Claim 2

A method comprising synthesising the (R) enantiomer of mequitazine from the (R) enantiomer of vinyl quinuclidine of the following formula 2:

### Claim 3 (depends on 2)

The method according to claim 2 comprising the following successive steps:
(a) oxidative cleavage of the double bond of the (R) enantiomer of the vinyl quinuclidine of formula 2 as defined in claim 2 to give the aldehyde of the following formula 8:
for which the carbon atom marked with a star is of (R) configuration,
(b) reduction of the aldehyde of formula 8 obtained at the preceding step (a) to give the alcohol of the following formula 9:
for which the carbon atom marked with a star is of (R) configuration,
(c) activation of the OH function of the alcohol of formula 9 obtained at the preceding step (b) to give
a compound of the following formula 10:
for which the carbon atom marked with a star is of (R) configuration and R3 represents a leaving group, and
(d) coupling of the compound of formula 10 obtained at the preceding step (c) with phenothiazine to give the (R) enantiomer of mequitazine.

### Claim 4 (depends on 3)

The method according to claim 3, wherein step (a) is carried out by ozonolysis.

### Claim 5 (depends on 2, 4)

The method according to claim 4, wherein step (a) is carried out from an acid addition salt of the (R) enantiomer of the vinyl quinuclidine of formula 2 as defined in claim 2.

### Claim 6 (depends on 3)

The method according to claim 3, wherein step (b) is carried out in the presence of a hydride.

### Claim 7 (depends on 6)

The method according to claim 6, wherein the hydride is NaBH4.

### Claim 8 (depends on 3)

The method according to claim 3, wherein R3 represents a mesylate (OMs).

### Claim 9 (depends on 8)

The method according to claim 8, wherein step (c) is carried out in the presence of mesyl chloride (MsCl) and a base.

### Claim 10 (depends on 9)

The method according to claim 9, wherein the base is pyridine.

### Claim 11 (depends on 3)

The method according to claim 3, wherein step (d) is carried out in the presence of a base.

### Claim 12 (depends on 11)

The method according to claim 11, wherein the base is potassium tert-butoxylate.
